Terug
Dagbereik
€ 184,99
€ 192,96
52-Weeksbereik
€ 171,00
€ 242,80
Volume
3.609.589
50D / 200D Gem.
€ 214,85
/
€ 210,29
Vorige Slotkoers
€ 190,10
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 36,6 | 0,2 |
| P/B | 2,5 | 3,0 |
| ROE % | 7,1 | 3,6 |
| Net Margin % | 14,7 | 3,8 |
| Rev Growth 5Y % | -4,4 | 9,7 |
| D/E | 0,4 | 0,2 |
Koersdoel Analisten
Hold
€ 253,75
+35.6%
Low: € 220,00
High: € 270,00
Forward K/W
22,25
Forward WPA
€ 8,41
WPA Groei (sch.)
+0,0%
Omzet Sch.
25,62B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 11,82
€ 11,61 – € 12,71
|
31,96B | 2 |
| FY2029 |
€ 10,88
€ 10,69 – € 11,70
|
30,50B | 2 |
| FY2028 |
€ 10,01
€ 8,82 – € 11,73
|
28,84B | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-28 | € 2,16 | € 2,23 | +3,2% |
| 2025-10-21 | € 1,72 | € 1,89 | +9,9% |
| 2025-07-22 | € 1,64 | € 1,80 | +9,8% |
| 2025-04-22 | € 1,63 | € 1,88 | +15,3% |
| 2025-01-29 | € 2,14 | € 2,14 | 0,0% |
| 2024-10-22 | € 1,57 | € 1,71 | +8,9% |
| 2024-07-23 | € 1,57 | € 1,72 | +9,6% |
| 2024-04-23 | € 1,72 | € 1,92 | +11,6% |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 1, 2026 |
McGrew Matthew
Executive Vice President
|
grant | 21.974 | — | — |
| Feb 24, 2026 |
Milosevich Gregory M
Executive Vice President
|
other | 189 | € 209,19 | € 39.536,91 |
| Feb 24, 2026 |
Gutierrez-Ramos Jose-Carlos
SVP, Chief Science Officer
|
other | 344 | € 209,19 | € 71.961,36 |
| Feb 24, 2026 |
Bouda Christopher
VP, Chief Accounting Officer
|
other | 235 | € 209,19 | € 49.159,65 |
| Feb 24, 2026 |
Sawyer Montgomery Julie A
Executive Vice President
|
other | 372 | € 209,19 | € 77.818,68 |
| Feb 24, 2026 |
Couchara Georgeann
SVP, Human Resources
|
other | 101 | € 209,19 | € 21.128,19 |
| Feb 24, 2026 |
Riley Christopher Paul
Executive Vice President
|
other | 242 | € 209,19 | € 50.623,98 |
| Feb 19, 2026 |
Milosevich Gregory M
Executive Vice President
|
other | 2.640 | € 58,59 | — |
| Feb 19, 2026 |
Milosevich Gregory M
Executive Vice President
|
sell | 1.320 | € 208,01 | € 274.574,52 |
| Feb 4, 2026 |
Blair Rainer
President & CEO
|
grant | 8.474 | — | — |
| Jan 30, 2026 |
List Teri
Director
|
grant | 11 | € 218,89 | € 2.407,79 |
| Jan 30, 2026 |
Sanders A Shane
Director
|
grant | 184 | € 218,89 | € 40.275,76 |
| Nov 15, 2025 |
GRAY R BRADLEY
SVP Strategic Development
|
other | 1.402 | € 221,21 | € 310.136,42 |
| Nov 10, 2025 |
Couchara Georgeann
SVP, Human Resources
|
other | 8.352 | € 88,24 | — |
| Nov 10, 2025 |
Couchara Georgeann
SVP, Human Resources
|
sell | 5.174 | € 210,44 | € 1.088.703,65 |
| Jul 15, 2025 |
Zerhouni Elias A.
Director
|
other | 9.065 | € 59,34 | — |
| Jul 2, 2025 |
List Teri
Director
|
other | 9.006 | € 59,34 | — |
| May 15, 2025 |
Blair Rainer
President & CEO
|
other | 27.490 | — | — |
| May 15, 2025 |
Couchara Georgeann
SVP, Human Resources
|
other | 281 | € 190,95 | € 53.656,95 |
| May 15, 2025 |
Zerhouni Elias A.
Director
|
grant | 2.055 | — | — |
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,24%
Growth (3Y)
8,58%
Growth (5Y)
12,20%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 27, 2026 | Apr 24, 2026 | € 0,40 | 0,73% |
| Dec 26, 2025 | Jan 30, 2026 | € 0,32 | 0,56% |
| Sep 26, 2025 | Oct 31, 2025 | € 0,32 | 0,67% |
| Jun 27, 2025 | Jul 25, 2025 | € 0,32 | 0,59% |
| Mar 28, 2025 | Apr 25, 2025 | € 0,32 | 0,55% |
| Dec 27, 2024 | Jan 31, 2025 | € 0,27 | 0,47% |
| Sep 27, 2024 | Oct 25, 2024 | € 0,27 | 0,38% |
| Jun 28, 2024 | Jul 26, 2024 | € 0,27 | 0,42% |
| Mar 27, 2024 | Apr 26, 2024 | € 0,27 | 0,41% |
| Dec 28, 2023 | Jan 26, 2024 | € 0,24 | 0,42% |
| Oct 11, 2023 | Oct 27, 2023 | € 0,27 | 0,45% |
| Jun 29, 2023 | Jul 28, 2023 | € 0,27 | 0,44% |
| Mar 30, 2023 | Apr 28, 2023 | € 0,27 | 0,41% |
| Dec 29, 2022 | Jan 27, 2023 | € 0,25 | 0,37% |
| Sep 29, 2022 | Oct 28, 2022 | € 0,25 | 0,37% |
| Jun 23, 2022 | Jul 29, 2022 | € 0,25 | 0,36% |
| Mar 24, 2022 | Apr 29, 2022 | € 0,25 | 0,31% |
| Dec 29, 2021 | Jan 28, 2022 | € 0,21 | 0,26% |
| Sep 29, 2021 | Oct 29, 2021 | € 0,21 | 0,26% |
| Jun 24, 2021 | Jul 30, 2021 | € 0,21 | 0,29% |
Belangrijkste Punten
Revenue declined -4,43% annually over 5 years
Debt/Equity of 0,35 — conservative balance sheet
Generating 5,26B in free cash flow
P/E of 36,62 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7,33%
Cash machine — converts 145,55% of earnings into free cash flow
Groei
Revenue Growth (5Y)
-4,43%
Revenue (1Y)2,90%
Earnings (1Y)-7,31%
FCF Growth (3Y)-4,61%
Kwaliteit
Return on Equity
7,08%
ROIC5,43%
Net Margin14,71%
Op. Margin20,91%
Veiligheid
Debt / Equity
0,35
Current Ratio1,87
Interest Coverage19,38
Waardering
P/E Ratio
36,62
Forward P/E22,25
P/B Ratio2,52
EV/EBITDA28,45
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,90% | Revenue Growth (3Y) | 1,41% |
| Earnings Growth (1Y) | -7,31% | Earnings Growth (3Y) | -12,90% |
| Revenue Growth (5Y) | -4,43% | Earnings Growth (5Y) | -13,42% |
| Profitability | |||
| Revenue (TTM) | 24,57B | Net Income (TTM) | 3,61B |
| ROE | 7,08% | ROA | 4,33% |
| Gross Margin | 60,93% | Operating Margin | 20,91% |
| Net Margin | 14,71% | Free Cash Flow (TTM) | 5,26B |
| ROIC | 5,43% | FCF Growth (3Y) | -4,61% |
| Safety | |||
| Debt / Equity | 0,35 | Current Ratio | 1,87 |
| Interest Coverage | 19,38 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,24% |
| Dividend Growth (3Y) | 8,58% | Dividend Growth (5Y) | 12,20% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 36,62 | Forward P/E | 22,25 |
| P/B Ratio | 2,52 | P/S Ratio | 5,39 |
| PEG Ratio | -9,18 | Forward PEG | N/A |
| EV/EBITDA | 28,45 | Fwd EV/EBITDA | 17,86 |
| Forward P/S | 5,16 | Fwd Earnings Yield | 4,49% |
| FCF Yield | 3,97% | ||
| Market Cap | 132,34B | Enterprise Value | 146,14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 24,57B | 23,88B | 23,89B | 26,64B | 29,45B |
| Net Income | 3,61B | 3,90B | 4,76B | 7,21B | 6,43B |
| EPS (Diluted) | 5,04 | 5,29 | 6,38 | 9,64 | 8,61 |
| Gross Profit | 14,97B | 14,21B | 14,03B | 16,19B | 17,95B |
| Operating Income | 5,14B | 5,18B | 5,28B | 7,54B | 8,05B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 83,46B | 77,54B | 84,49B | 84,35B | 83,18B |
| Total Liabilities | 30,93B | 27,99B | 31,00B | 34,26B | 38,01B |
| Shareholders' Equity | 52,53B | 49,54B | 53,49B | 50,08B | 45,17B |
| Total Debt | 18,42B | 17,15B | 19,54B | 20,62B | 23,27B |
| Cash & Equivalents | 4,62B | 2,08B | 5,86B | 6,00B | 2,59B |
| Current Assets | 12,76B | 9,50B | 13,94B | 15,88B | 11,65B |
| Current Liabilities | 6,81B | 6,80B | 8,27B | 8,39B | 8,14B |